1. Home
  2. NQP vs KMDA Comparison

NQP vs KMDA Comparison

Compare NQP & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NQP
  • KMDA
  • Stock Information
  • Founded
  • NQP 1990
  • KMDA 1990
  • Country
  • NQP United States
  • KMDA Israel
  • Employees
  • NQP N/A
  • KMDA N/A
  • Industry
  • NQP Trusts Except Educational Religious and Charitable
  • KMDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • NQP Finance
  • KMDA Health Care
  • Exchange
  • NQP Nasdaq
  • KMDA Nasdaq
  • Market Cap
  • NQP 413.9M
  • KMDA 430.1M
  • IPO Year
  • NQP N/A
  • KMDA N/A
  • Fundamental
  • Price
  • NQP $10.87
  • KMDA $7.35
  • Analyst Decision
  • NQP
  • KMDA Strong Buy
  • Analyst Count
  • NQP 0
  • KMDA 2
  • Target Price
  • NQP N/A
  • KMDA $13.00
  • AVG Volume (30 Days)
  • NQP 58.4K
  • KMDA 49.4K
  • Earning Date
  • NQP 01-01-0001
  • KMDA 08-13-2025
  • Dividend Yield
  • NQP 3.21%
  • KMDA 2.72%
  • EPS Growth
  • NQP N/A
  • KMDA 27.97
  • EPS
  • NQP N/A
  • KMDA 0.32
  • Revenue
  • NQP N/A
  • KMDA $169,517,000.00
  • Revenue This Year
  • NQP N/A
  • KMDA $14.51
  • Revenue Next Year
  • NQP N/A
  • KMDA $9.31
  • P/E Ratio
  • NQP N/A
  • KMDA $22.26
  • Revenue Growth
  • NQP N/A
  • KMDA 9.67
  • 52 Week Low
  • NQP $9.65
  • KMDA $5.17
  • 52 Week High
  • NQP $11.89
  • KMDA $9.16
  • Technical
  • Relative Strength Index (RSI)
  • NQP 41.89
  • KMDA 48.99
  • Support Level
  • NQP $10.97
  • KMDA $7.15
  • Resistance Level
  • NQP $11.03
  • KMDA $7.85
  • Average True Range (ATR)
  • NQP 0.07
  • KMDA 0.22
  • MACD
  • NQP 0.01
  • KMDA 0.00
  • Stochastic Oscillator
  • NQP 33.33
  • KMDA 54.13

About NQP Nuveen Pennsylvania Quality Municipal Income Fund

Nuveen Pennsylvania Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal and Pennsylvania income taxes and to enhance portfolio value relative to the municipal bond market by investing in municipal securities that are exempt from federal, Pennsylvania state and local income taxes. It invests a majority of its assets in securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: